Welche Maßnahmen sind bei Clostridium-difficile-Toxin-Nachweis erforderlich?

Literatur

• 1 Bartlett J G, Chang T W, Gurwith M, Gorbach S L, Onderdonk A B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.  Engl J Med. 1978;  298 531-534
• 2 Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.  Am J Gastroenterol. 1997;  92 739-750
• 3 Jobe B A, Grasley A, Deveney K E, Deveney C W, Sheppard B C. Clostridium difficile colitis: an increasing hospital-acquired illness.  Am J Surg. 1995;  169 480-483
• 4 Kelly C P, Pothoulakis C, LaMont  J T. Clostridium difficile colitis.  N Engl J Med. 1994;  330 257-262
• 5 Kelly C P, LaMont J T. Clostridium difficile infection.  Annu Rev Med. 1998;  49 375-390
• 6 Larson H E, Parry J V, Price A B, Davies D R, Dolby J, Tyrell D A. Undescribed toxin in pseudomembranous colitis.  Br Med J. 1977;  1 1246-1248
• 7 Lyerly D M, Neville L M, Evans D T, Fill J, Allen S, Greene W, Sautter R, Hnatuck P, Torpey D J, Schwalbe R. Multicenter evaluation of the Clostridium difficile TOX A/B TEST.  J Clin Microbiol. 1998;  36 184-190
• 8 Mitty R D, Lamont J T. Clostridium difficile colitis: epidemiology, pathophysiology and treatment.  Mt Sinai J Med. 1994;  61 329-335

Autor